Literature DB >> 28060949

Health Related Quality of Life in a Dutch Rehabilitation Population: Reference Values and the Effect of Physical Activity.

Leonie A Krops1, Eva A Jaarsma1, Pieter U Dijkstra1,2, Jan H B Geertzen1, Rienk Dekker1,3.   

Abstract

PURPOSE: To establish reference values for Health Related Quality of Life (HRQoL) in a Dutch rehabilitation population, and to study effects of patient characteristics, diagnosis and physical activity on HRQoL in this population.
METHOD: Former rehabilitation patients (3169) were asked to fill in a questionnaire including the Dutch version of the RAND-36. Differences between our rehabilitation patients and Dutch reference values were analyzed (t-tests). Effects of patient characteristics, diagnosis and movement intensity on scores on the subscales of the RAND-36 were analyzed using block wise multiple regression analyses.
RESULTS: In total 1223 patients (39%) returned the questionnaire. HRQoL was significantly poorer in the rehabilitation patients compared to Dutch reference values on all subscales (p<0.001) except for health change (p = 0.197). Longer time between questionnaire and last treatment was associated with a smaller health change (p = 0.035). Higher age negatively affected physical functioning (p<0.001), social functioning (p = 0.004) and health change (p = 0.001). Diagnosis affected outcomes on all subscales except role limitations physical, and mental health (p ranged <0.001 to 0.643). Higher movement intensity was associated with better outcomes on all subscales except for mental health (p ranged <0.001 to 0.190).
CONCLUSIONS: HRQoL is poorer in rehabilitation patients compared to Dutch reference values. Physical components of HRQoL are affected by diagnosis. In rehabilitation patients an association between movement intensity and HRQoL was found. For clinical purposes, results of this study can be used as reference values for HRQoL in a rehabilitation setting.

Entities:  

Mesh:

Year:  2017        PMID: 28060949      PMCID: PMC5217970          DOI: 10.1371/journal.pone.0169169

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

During the past decades, the perspective on health care shifted from mainly biomedical to more biopsychosocial [1]. In the biopsychosocial model, health is described as an interaction between biological, psychological and social aspects [2]. Health Related Quality of Life (HRQoL) is a typical example of a biopsychosocial construct, by its biological (i.e. physical functioning), psychological (i.e. mental health) and social aspects (i.e. social functioning) [3]. Through this shift in health perspective, improving HRQoL tends to become of more importance in present health care. This shift in perspective went simultaneously with an increased demand towards measuring the effectiveness of health care [3]. Taking this together, this highlights the importance of measuring HRQoL in today’s health care [4]. Especially in rehabilitation, improving HRQoL is one of the important goals because of the permanent effects of most impairments. In the treatment of Multiple Sclerosis (MS) patients, HRQoL forms an important consideration [5] since it is highly sensitive to changes in disease status. HRQoL is frequently assessed by using the Short Form– 36 (SF-36), as compiled by the Medical Outcome Study [6]. The SF-36 is highly correlated (0.99) with the RAND-36. Both questionnaires consist of exactly the same 36 items, and only differ slightly in the scoring procedure [7]. Additional to the shared 8 subscales, the RAND-36 has a subscale “health change over the past year”. In earlier research, quality of life in rehabilitation outpatients proved to be lower compared to the general population [8]. That study used the abbreviated version of the World Health Organization Quality of Life questionnaire, whereby Quality of Life is divided in different subscales compared to the RAND-36 or SF-36. Four studies measured HRQoL using the RAND-36 in a diagnosis group that is represented in the rehabilitation population of the current study [9-12]. Only for people with a lower limb amputation, we found HRQoL as measured by the Dutch translation of the RAND-36 [10,12]. Lower limb amputees scored lower on physical functioning, role limitations–physical and pain compared to control subjects [10]. To the best of our knowledge, besides these four studies, HRQoL was only measured with the SF-36 in different non-Dutch populations, for the diagnoses in the current study [13-39]. Since the SF-36 does not include the health change element, reference values for that element were not present. In general HRQoL was lower in lower limb amputee patients, chronic pain patients, MS patients and spinal cord injured (SCI) patients compared to the general population [9,10,13-15,25,34,38]. Most studies on HRQoL focus on only a small part of the rehabilitation population. However, including various diagnoses of the rehabilitation population allows also a direct comparison of HRQoL between these diagnoses. The aim of the current study is establish reference values for HRQoL in a Dutch rehabilitation population, and to study effects of patient characteristics, diagnosis and physical activity on HRQoL in this population.

Methods

Participants

A total of 3169 rehabilitation patients were invited to participate in this study. All of them completed their rehabilitation program in the Center for Rehabilitation of the University Medical Center Groningen, the Netherlands. All rehabilitation patients of 18 years or older, treated between the 1st of January 2009 and 31st December 2011 were invited. Excluded were cardiac or pulmonary rehabilitation patients since they were treated in a different treatment framework, and patients with a diagnosis of orthopedic origin since they were treated mostly monodisciplinary.

Questionnaire

Participants were asked to fill in a questionnaire including the validated Dutch version of the RAND-36 [40,41] and questions on sports participation [42]. The RAND-36 is a profile based measurement instrument, of which scores on the following 9 subscales are calculated: Physical functioning, Social functioning, Role limitations–physical, Role limitations–emotional, Mental health, Pain, Vitality, General health and Health change.

Procedure

The patient’s names, addresses, diagnosis, gender, date of birth, and date of last treatment were retrieved from the database of the Center for Rehabilitation of the University Medical Center Groningen. All potential participants received the questionnaire including a cover letter and an informed consent form by post. Potential participants were asked to either fill in and return the paper questionnaire, or fill in the online questionnaire, by using the provided link. After being informed that participation was voluntary and data would be processed anonymously, participants gave their written informed consent. Participants who completed the online questionnaire were asked to return their written informed consent by post. Moreover we assumed that by filling in the questionnaire, the participant declared willingness to participate. Online questionnaires were filled in using the Unipark software (QuestBack GmbH, Berlin, Germany) which fulfills data protection and security requirements (ISO 27001). Prior to sending the questionnaire, all potential participants were coded using a participant number. The online questionnaire was filled in using provided login credentials which were based on the participant number. The paper questionnaire was also coded with the predetermined participant number, whereby no information that can lead to the participant was present on the questionnaire, except for the participant number of which the key was only available to the involved researchers. The study protocol was approved by the Medical Ethical Committee of the University Medical Center Groningen, the Netherlands (METc 2012.450).

Data analysis

Differences between participants and non-participants were analyzed using independent samples t-tests (age and follow-up period) and chi squared tests (diagnoses and gender). Despite scores on some of the subscales were non-normally distributed (skewness and kurtosis divided by their standard deviation > 1.96), differences between participants and a healthy Dutch reference population [40] for all 9 subscales were analyzed using independent samples t-tests, because of the large sample size. Radar plots were created to elucidate the scores on the subscales for different diagnoses, and for the entire rehabilitation population in comparison to Dutch reference values. Multiple regression analyses were performed to statistically predict scores on the 9 subscales based on follow up (months between last treatment and questionnaire), gender, age, diagnosis and movement intensity. Predictors were entered block wise. Patient characteristics were entered first, diagnosis was entered second, and movement intensity was entered third. When significant effects for movement intensity and for any other predictor were found, interaction effects between these predictors were explored and entered as a fourth block. Movement intensity was calculated by multiplying the activity specific intensity (MET) [43] with the number of hours per week that the activity was performed. Diagnoses were entered using dummy variables, in which MS formed the reference group. Statistical analyses were performed using SPSS 20.1 (IBM, New York). The level of significance was set at p < 0.05.

Results

A total of 1223 patients (39%) completed the questionnaire (Table 1), of whom 1113 persons (91%) responded using the paper questionnaire, and 110 persons (9%) filled in the online questionnaire. Participants were older compared to non-participants (t = -8.903 (2746.7); p < 0.001). The distribution of diagnoses differed between participants and non-participants (X2 = 31.156 (6); p <0.001). No differences between participants and non-participants were found regarding gender (X2 = 0.821 (1); p = 0.365) and follow up period (t = 1.001 (3167); p = 0.317) (Table 1). Missing items per question ranged from 0.4 to 10.8%, and scores on subscales missed in 0.1 to 8.2% of the participants. HRQoL was significantly lower in the current rehabilitation population compared to the healthy reference population [40] on all subscales except for the health change subscale (Table 2, Fig 1). Results of the multiple regression analyses investigating the effect of follow up, gender, age, diagnosis and activity intensity on HRQoL are presented in Table 3. Follow-up negatively affected health change (p = 0.035), whereas age has a negative effect on physical functioning (p <0.001), social functioning (p = 0.004) and health change (p = 0.001). Diagnosis was affecting all subscales except for role limitations physical and mental health (p ranged <0.001 to 0.643). Movement intensity positively influenced all subscales except mental health (p ranged <0.001 to 0.190). The effect of diagnosis on the different subscales of the RAND-36 is displayed in Fig 2. Scores on the RAND-36 for the different subgroups of our rehabilitation population are presented in S1 Appendix.
Table 1

Characteristics of the participants and non-participants.

Participants (n = 1223)Non-participants (n = 1946)Difference (95% CI)p-value
Mean±SDMean±SD
Age (years) *53.9±14.349.1±15.6-4.8 (-5.9; -3.8)<0.001
Follow up (months)29.1±10.529.5±10.50.4 (-0.4; 1.1)0.317
n (%)n (%)
Gender (men)609 (50)931 (48)0.365
Diagnosis *<0.001
Amputation49 (4)77 (4)
Brain injury a418 (34)564 (29)
Chronic pain334 (27)664 (34)
Multiple sclerosis73 (6)98 (5)
Spinal cord injury98 (8)67 (3)
Other neurological disabilities b99 (8)214 (11)
Other disabilities c152 (12)270 (14)

* significant difference between participants and non-participants

a Brain injuries from vascular, traumatic or oncological origin and meningitis

b Spina bifida, Parkinson’s Disease and Guillain-Barré Syndrome

c Disabilities such as tumors, fibromyalgia, arthritis, multi trauma, chronic fatigue syndrome and decubitus ulcer.

Table 2

Difference in HRQoL between the current rehabilitation population and a healthy Dutch reference population [40].

Rehabilitation aHealthy a,bDifference95% CIt-valuep-value
PF51.6±31.781.9±23.2-30.328.03; 32.5725.68<0.001
SF64.6±27.186.9±20.5-22.320.34; 24.2621.92<0.001
RP43.1±40.679.4±35.5-36.333.11; 39.4922.20<0.001
RE70.5±40.884.1±32.3-13.610.53; 16.678.62<0.001
MH65.2±15.176.8±18.4-11.610.21; 12.9916.52<0.001
VT52.1±16.667.4±19.9-15.313.78; 16.8219.99<0.001
BP65.2±26.679.5±25.6-14.312.16; 16.4413.03<0.001
GH54.7±21.172.7±22.7-18.016.19; 19.8119.61<0.001
HC51.2±24.352.4±19.4-1.2-0.60; 3.001.290.197

a mean±SD

b Results of a Dutch reference population [40]; PF = physical functioning; SF = social functioning; RP = role limitations–physical; RE = role limitations–emotional; MH = mental health; VT = vitality; BP = pain; GH = general health; HC = health change; 95% CI = 95% confidence interval

Fig 1

Health related quality of life in rehabilitation and healthy individuals [40].

Dotted line = rehabilitation patients; solid line = healthy reference population [40]. Asterisks indicate significant differences between the rehabilitation patients and healthy individuals. PF = physical functioning; SF = social functioning; RP = role limitations–physical; RE = role limitations–emotional; MH = mental health; VT = vitality; BP = pain; GH = general health; HC = health change.

Table 3

Results of the multiple regression analyses for all nine subscales of the RAND-36.

SubscalePredictorCoëfficiënt (SE)95% CIp-valueR2 change
PFCharacteristics<0.0010.075
Follow-up a-0.8*10−2 (0.8*10−1)-0.2; 0.20.922
Gender b1.5 (1.7)-1.9; 4.90.401
Age c-0.5 (0.1)-0.7; -0.4<0.001
Diagnosis d<0.0010.139
Amputation0.9 (6.3)-11.4; 13.10.888
Spinal cord injury-9.1 (5.3)-19.5; 1.30.087
Brain injury e18.5 (4.1)10.4; 26.6<0.001
Chronic pain29.9 (4.3)21.5; 38.2<0.001
Other neurological disability f4.8 (5.2)-5.3; 14.90.354
Other g16.9 (4.7)7.6; 26.1<0.001
Movement intensity<0.0010.064
Movement intensity h0.2 (0.3)-0.3; 0.70.439
Interaction terms<0.0010.020
Age * movement0.7*10−2 (0.3*10−2)0.2*10−2; 0.1*10−10.007
Amputation * movement-0.6 (0.3)-1.1; -0.7*10−10.028
Spinal cord injury * movement-0.1 (0.3)-0.6; 0.40.658
Brain injury * movement-0.2*10−1 (0.2)-0.5; 0.50.942
Chronic pain * movement-0.3 (0.2)-0.8; 0.20.200
Other neurological disability * movement-0.2 (0.3)-0.8; 0.30.848
Other * movement
Constant55.8 (5.8)44.5; 67.1<0.001
SFCharacteristics0.0190.010
Follow-up0.7*10−1 (0.8*10−1)-0.1; 0.20.423
Gender-1.3 (1.7)-4.6; 2.10.467
Age-0.2 (0.7*10−1)-0.4; -0.7*10−10.004
Diagnosis0.0050.013
Amputation7.0 (6.2)-5.1; 19.10.257
Spinal cord injury4.8 (5.2)-5.4; 15.00.357
Brain injury-0.3 (4.1)-8.4; 7.80.946
Chronic pain8.3 (4.3)-0.6*10−1; 16.70.052
Other neurological disability9.2 (5.1)-0.8; 19.30.072
Other8.8 (4.7)-0.4; 18.10.060
Movement intensity<0.0010.009
Movement intensity0.5*10−1 (0.3)-0.5; 0.60.846
Interaction terms<0.0010.014
Age * movement0.6*10−2 (0.3*10−2)0.1*10−2; 0.1*10−10.022
Amputation * movement-0.5 (0.3)-1.0; 0.8*10−10.094
Spinal cord injury * movement-0.2 (0.3)-0.7; 0.30.402
Brain injury * movement-0.9*10−1 (0.2)-0.6; 0.40.699
Chronic pain * movement-0.3 (0.2)-0.8; 0.20.225
Other neurological disability * movement-0.2 (0.3)-0.7; 0.30.486
Other * movement-0.3 (0.2)-0.8; 0.20.243
Constant67.2 (5.7)56.0; 78.5<0.001
RPCharacteristics0.0870.007
Follow-up0.1 (0.1)-0.1; 0.40.375
Gender-2.2 (2.7)-7.5; 3.10.410
Age-0.1 (0.1)-0.3; 0.6*10−10.165
Diagnosis0.3430.004
Amputation5.3 (8.9)-12.3; 22.90.554
Spinal cord injury6.4 (7.5)-8.4; 21.20.395
Brain injury4.8 (5.8)-6.5; 16.10.401
Chronic pain4.2 (5.9)-7.3; 15.70.472
Other neurological disability0.5 (6.6)-12.5; 13.40.946
Other7.4 (6.4)-5.7; 20.40.268
Movement intensity0.0010.021
MET * hr/wk0.3 (0.1)0.2; 0.4<0.001
Constant32.3 (8.3)22.0; 54.5<0.001
RECharacteristics0.0880.007
Follow-up0.2 (0.1)-0.3*10−1; 0.50.084
Gender0.9; 2.7-4.5; 6.30.744
Age-0.1 (0.1)-0.3; 0.10.297
Diagnosis0.0020.021
Amputation-0.8 (10.4)-21.2; 19.60.938
Spinal cord injury5.4 (8.5)-11.4; 22.10.528
Brain injury-10.2 (6.7)-23.4; 2.90.127
Chronic pain5.5 (6.8)-8.0; 19.00.422
Other neurological disability2.4 (8.2)-13.7; 18.40.774
Other3.9 (7.7)-11.2; 18.90.615
Movement intensity<0.0010.006
Movement intensity0.2*10−1 (0.4)-0.7; 0.70.957
Interaction terms0.0040.003
Amputation * movement0.3 (0.5)-0.6; 1.20.476
Spinal cord injury * movement0.2*10−1 (0.4)-0.8; 0.80.954
Brain injury * movement0.2 (0.4)-0.5; 1.00.546
Chronic pain * movement0.3*10−1 (0.4)-0.7; 0.80.945
Other neurological disability * movement0.9*10−1 (0.4)-0.7; 0.90.824
Other * movement0.2 (0.4)-0.6; 1.00.595
Constant66.7 (8.8)49.4; 84.0<0.001
MHCharacteristics0.5980.002
Follow-up0.6*10−1 (0.5*10−1)-0.3*10−1; 0.20.189
Gender-0.7 (1.0)-2.6; 1.30.502
Age0.2*10−1 (0.4*10−1)-0.5*10−1; 0.9*10−10.601
Diagnosis0.6430.005
Amputation1.5 (3.2)-4.7; 7.70.642
Spinal cord injury1.2 (2.7)-4.1; 6.40.668
Brain injury-1.0 (2.1)-5.1; 3.10.632
Chronic pain1.1 (2.1)-3.1; 5.30.617
Other neurological disability1.5 (2.4)-3.3; 6.20.545
Other1.3 (2.4)-3.4; 6.10.578
Movement intensity0.1900.007
Movement intensity0.6*10−1 (0.2*10−1)0.2*10−1; 0.10.010
Constant61.1 (3.0)55.3; 67.0<0.001
VTCharacteristics0.0310.009
Follow-up0.9*10−1 (0.5*10−1)-0.9*10−2; 0.20.076
Gender1.1 (1.1)-0.9; 3.20.278
Age-0.2*10−1 (0.4*10−1)-0.9*10−1; 0.5*10−10.623
Diagnosis0.0040.015
Amputation9.5 (3.7)2.1; 16.90.011
Spinal cord injury6.8 (3.2)0.6; 13.10.031
Brain injury2.4 (2.5)-2.5; 7.30.340
Chronic pain2.7 (2.6)-2.4; 7.80.299
Other neurological disability4.3 (3.4)-1.9; 10.40.176
Other4.1 (2.9)-1.5; 9.80.151
Movement intensity<0.0010.033
Movement intensity0.3 (0.1)0.3*10−1; 0.60.030
Interaction terms<0.0010.005
Amputation * movement-0.2 (0.2)-0.5; 0.20.317
Spinal cord injury * movement-0.2 (0.2)-0.5; 0.9*10−10.167
Brain injury * movement-0.1 (0.1)-0.4; 0.10.321
Chronic pain * movement-0.2 (0.1)-0.5; 0.8*10−10.147
Other neurological disability * movement-0.8*10−1 (0.2)-0.4; 0.20.603
Other * movement-0.9*10−1 (0.2)-0.4; 0.20.554
Constant44.0 (3.3)37.6; 50.4<0.001
BPCharacteristics0.0160.010
Follow-up0.4*10−1 (0.8*10−1)-0.1; 0.20.598
Gender3.0 (1.7)-0.3; 6.30.073
Age-0.7*10−1 (0.6*10−1)-0.2; 0.4*10−10.218
Diagnosis<0.0010.063
Amputation-0.7 (5.9)-12.3; 11.00.910
Spinal cord injury-3.4 (5.0)-13.2; 6.40.494
Brain injury6.1 (4.0)-1.7; 13.80.128
Chronic pain-11.1 (4.1)-19.2; -3.10.007
Other neurological disability-3.9 (4.9)-13.6; 5.70.426
Other-7.2 (4.5)-16.1; 1.70.114
Movement intensity<0.0010.013
Movement intensity0.3 (0.2)-0.2; 0.70.215
Interaction terms<0.0010.005
Amputation * movement-0.3 (0.3)-0.9; 0.20.200
Spinal cord injury * movement-0.3 (0.3)-0.8; 0.20.293
Brain injury * movement-0.8*10−1 (0.2)-0.5; 0.40.732
Chronic pain * movement-0.1 (0.2)-0.6; 0.30.648
Other neurological disability * movement-0.2 (0.3)-0.7; 0.30.415
Other * movement0.4*10−1 (0.2)-0.5; 0.40.874
Constant65.7 (5.2)55.5; 75.9<0.001
GHCharacteristics0.0150.010
Follow-up0.7*10−1 (0.6*10−1)-0.5*10−1; 0.20.231
Gender-2.3 (1.3)-4.9; 0.20.076
Age-0.7*10−1 (0.5*10−1)-0.2; 0.2*10−10.113
Diagnosis<0.0010.035
Amputation8.2 (4.7)-0.9; 17.40.078
Spinal cord injury13.7 (3.9)6.0; 21.40.001
Brain injury11.3 (3.1)5.2; 17.4<0.001
Chronic pain13.4 (3.2)7.0; 19.7<0.001
Other neurological disability7.0 (3.9)-0.5; 14.60.069
Other8.9 (3.6)1.9; 15.80.013
Movement intensity<0.0010.039
Movement intensity0.2 (0.2)-0.2; 0.50.278
Interaction terms<0.0010.007
Amputation * movement0.3*10−1 (0.2)-0.4; 0.40.894
Spinal cord injury * movement-0.1 (0.2)-0.5; 0.30.609
Brain injury * movement0.9*10−1 (0.2)-0.3; 0.50.611
Chronic pain * movement-0.4*10−1 (0.2)-0.4; 0.30.835
Other neurological disability * movement-0.1 (0.2)-0.5; 0.30.549
Other * movement0.1 (0.2)-0.2; 0.50.489
Constant43.4 (4.1)35.4; 51.5<0.001
HCCharacteristics<0.0010.026
Follow-up-0.2 (0.9*10−1)-0.4; -0.1*10−10.035
Gender-0.8 (1.5)-3.8; 2.10.581
Age-0.2 (0.6*10−1)-0.3; -0.8*10−10.001
Diagnosis<0.0010.025
Amputation16.9 (5.3)6.4; 27.40.002
Spinal cord injury16.2 (4.5)7.3; 25.1<0.001
Brain injury14.2 (3.6)7.2; 21.3<0.001
Chronic pain16.7 (3.7)9.4; 23.9<0.001
Other neurological disability10.9 (4.5)2.2; 19.70.014
Other18.5 (4.1)10.5; 26.5<0.001
Movement intensity<0.0010.042
Movement intensity0.7 (0.3)0.2; 1.30.004
Interaction terms<0.0010.014
Follow up * movement-0.6*10−2 (0.3*10−2)-0.1*10−1; 0.1*10−20.075
Age * movement0.4*10−2 (0.2*10−2)<0.1*10−2; 0.9*10−20.078
Amputation * movement-0.6 (0.5)-1.1; -0.20.009
Spinal cord injury * movement-0.5 (0.2)-1.0; -0.6*10−10.026
Brain injury * movement-0.5 (0.2)-0.9; -0.9*10−10.016
Chronic pain * movement-0.5 (0.2)-0.9; -0.10.010
Other neurological disability * movement-0.5 (0.2)-0.9; -0.2*10−10.043
Other * movement-0.6 (0.2)-1.0; -0.20.007
Constant48.9 (5.2)38.7; 59.1<0.001

a Follow-up in months

b Reference = female

c Age in years

d Reference = Multiple sclerosis

e Brain injuries from vascular, traumatic or oncological origin and meningitis

f Spina bifida, Parkinson’s Disease and Guillain-Barré Syndrome

g Disabilities such as tumors, fibromyalgia, arthritis, multi trauma, chronic fatigue syndrome and decubitus ulcer

h Movement intensity expressed as MET * hr/wk; PF = physical functioning; SF = social functioning; RP = role limitations–physical; RE = role limitations–emotional; MH = mental health; VT = vitality; BP = pain; GH = general health; HC = health change; SE = standard error; 95% CI = 95% confidence interval.

Fig 2

Health related quality of life separated for different diagnosis groups.

Green solid line = amputation; green dotted line = spinal cord injury; blue solid line = brain injury; blue dotted line = multiple sclerosis; red solid line = chronic pain; red dotted line = other neurological disease; black line = other patients. Asterisks indicate significant differences between different diagnoses groups. PF = physical functioning; SF = social functioning; RP = role limitations–physical; RE = role limitations–emotional; MH = mental health; VT = vitality; BP = pain; GH = general health; HC = health change.

Health related quality of life in rehabilitation and healthy individuals [40].

Dotted line = rehabilitation patients; solid line = healthy reference population [40]. Asterisks indicate significant differences between the rehabilitation patients and healthy individuals. PF = physical functioning; SF = social functioning; RP = role limitations–physical; RE = role limitations–emotional; MH = mental health; VT = vitality; BP = pain; GH = general health; HC = health change.

Health related quality of life separated for different diagnosis groups.

Green solid line = amputation; green dotted line = spinal cord injury; blue solid line = brain injury; blue dotted line = multiple sclerosis; red solid line = chronic pain; red dotted line = other neurological disease; black line = other patients. Asterisks indicate significant differences between different diagnoses groups. PF = physical functioning; SF = social functioning; RP = role limitations–physical; RE = role limitations–emotional; MH = mental health; VT = vitality; BP = pain; GH = general health; HC = health change. * significant difference between participants and non-participants a Brain injuries from vascular, traumatic or oncological origin and meningitis b Spina bifida, Parkinson’s Disease and Guillain-Barré Syndrome c Disabilities such as tumors, fibromyalgia, arthritis, multi trauma, chronic fatigue syndrome and decubitus ulcer. a mean±SD b Results of a Dutch reference population [40]; PF = physical functioning; SF = social functioning; RP = role limitations–physical; RE = role limitations–emotional; MH = mental health; VT = vitality; BP = pain; GH = general health; HC = health change; 95% CI = 95% confidence interval a Follow-up in months b Reference = female c Age in years d Reference = Multiple sclerosis e Brain injuries from vascular, traumatic or oncological origin and meningitis f Spina bifida, Parkinson’s Disease and Guillain-Barré Syndrome g Disabilities such as tumors, fibromyalgia, arthritis, multi trauma, chronic fatigue syndrome and decubitus ulcer h Movement intensity expressed as MET * hr/wk; PF = physical functioning; SF = social functioning; RP = role limitations–physical; RE = role limitations–emotional; MH = mental health; VT = vitality; BP = pain; GH = general health; HC = health change; SE = standard error; 95% CI = 95% confidence interval.

Discussion

This study aimed to establish the HRQoL as measured using the RAND-36 in a Dutch rehabilitation population, and to identify factors influencing HRQoL in this diverse population. Participation in this study was 39%. This percentage is lower than in a study in both Dutch community dwelling and chronic disease populations of which a part was face-to-face interviewed [44], and little higher compared to a study in healthy individuals in the Netherlands [45]. Participants in the current study were ex-patients, and thereby familiar with our institute. Presumably, this may explain the little higher response rate in the current study compared to the earlier study in the Netherlands [45]. Non-responding may lead to non-response bias. From baseline characteristics it is known that participants differed from non-participants only on age and diagnosis. Participants were significantly older compared to non-participants. This is in agreement with overall trends in questionnaire based research [46], and is suggested to be explained by age-related moral differences on responding questionnaires. From the multiple regression analyses it can be concluded that age negatively affects scores on physical functioning, social functioning, general health and health change. Therefore, it is plausible that results on these subscales are underestimated by the representation of the sample. However, the highest coefficient on age was -0.5, and since the age differed only 5.1 years on average between the participants and non-participants, this will maximally have an effect of -2.6 on a scale ranging 0 to 100. The group of participants included substantially more brain injury and SCI patients, and less patients suffering from chronic pain and other neurological diseases compared to the non-participants. However, by the large number of participants and the relatively small differences in coefficients in the multiple regression analysis between these specific diagnoses, we assume that the different distribution of diagnoses between the participants and non-participants was not substantially influencing the results of this study. Our rehabilitation population scored lower on all subscales except for the health change subscale, when comparing to a healthy Dutch reference population (Table 2, Fig 1) [40]. This seems straightforward, because of the physical disabilities that the rehabilitation population suffer with, and is in accordance with earlier research [9,10,13-15,25,34,38]. In chronic disease patients, the discrimination for clinically relevant changes in HRQoL is indicated to be 0.5 SD [47]. Using this indication, the significant differences mentioned above are also clinically relevant. Compared to the rehabilitation population, the reference population was younger and consisted of a higher proportion of females. However, we think these differences will not have a large impact on comparisons made, since the coefficients of age and gender found in the multiple regression analyses are very small relatively compared to the differences between the populations. No significant differences were found on the health change subscale between the two populations. This implies that the health of the rehabilitation patients did not change faster or slower than that of the healthy population. This seems evident since the included rehabilitation patients are in the chronic phase, in which no major changes are expected anymore. When comparing the current results with the reference values, a time difference of approximately 20 years between these two measures, with probably an associated change on health perspective has to be taken into account. However, differences between both groups are that large that we assume this time difference will not have biased the conclusions. Multiple regression analyses (Table 3) showed that follow-up only influenced scores on health change. Health change was negatively affected by follow-up period, which implies that a longer follow-up leads to a smaller health change. This finding is clinical probable since the amount of progression stagnates over time. Gender was not associated with any of the subscales, which is in accordance with findings in healthy people [40]. Age had a negative effect on physical functioning, social functioning and health change, what indicates that level of physical functioning and social functioning are lower at higher age, and that health changes on a slower pace at higher age. The effects on physical functioning and health change are in accordance with findings in healthy people [40]. In healthy people age did not affected social functioning [40]. Diagnosis affected outcomes on all subscales except for role limitations physical and mental health. However, due to the large sample size not all statistically significant differences are clinically relevant. Following the rule of the thumb of half a SD [47], clinically relevant differences between diagnoses were found only on physical functioning, pain, general health and health change (S1 Appendix, Fig 2). It is remarkable that all these subscales are predominantly in the physical field. So unless rehabilitation patients in general have decreased psychosocial status compared to healthy individuals, no clinically relevant differences between the diagnoses can be found on those psychosocial subscales. In general, MS patients have a relatively low HRQoL and chronic pain patients have a relatively high HRQoL (Fig 2). This is contrary to findings in rehabilitation outpatients, in which chronic pain patients scored lower compared to other diagnoses [8]. Chronic pain patients in the current study form a too positive representation of the chronic pain population, since only chronic pain patients in which progress is expected, that with higher physical functioning in general, are admitted for rehabilitation and thus were included in the current study. Movement intensity was positively related to outcomes on all subscales except for mental health. This implies that being more physically active is associated with an increased HRQoL in bio-, psycho- and social domains. The positive effect of movement intensity can be due to the energy cost of the activity performed (amount of MET) or by the duration of the activity (hours/week). However, since no causal relationship can be established through the cross-sectional design of this study, it can also be that people with a higher HRQoL are more physically active. Coefficients of movement intensity appear to be relatively small, however the mean metabolic equivalent (MET value) of the activities performed by the active part of the group was 4.9. Performing one hour of such an average activity per week, would thereby increase the score on the subscale with 4.9 multiplied by the coefficient. In this study the 2011 compendium of Ainsworth was used to connect MET values to specific activities [43]. However, values in this compendium are calculated for healthy people. No MET values appropriate for people with physical disabilities were available. A significant positive interaction effect between age and movement intensity was found on physical functioning and social functioning. This implies that physical activity has a stronger effect on physical- and social functioning in older people compared to younger people. Moreover, significant interaction effects were found between several diagnoses and movement intensity on physical functioning and health change. All significant interaction effects were negative, which implies that movement is affecting physical functioning and health change less, in people suffering from that diagnosis compared to MS patients (reference population). To the best of our knowledge this is the first study investigating these interactions, whereby it was not possible to compare the current results to earlier findings. The explained variances of the multiple regression analyses range from 1.3% in the mental health subscale to 29.8% in the physical functioning subscale. Especially the explained variance by diagnoses is not very high in some subscales, which may be related to variability within diagnoses groups (severity of injury, level of amputation or level of SCI). Due to the large number of different diagnoses in this study, we have chosen to distinguish diagnosis only. Subdividing based on severity of injury would have led to even more (small) subgroups. The aim of this study was to overview the HRQoL of the Dutch rehabilitation population. By the diverse diagnoses in this study, results of this study provide insights in differences on HRQoL between those different diagnoses. This study is limited by the fact that all included patients were treated in one rehabilitation center in the north of the Netherlands, and almost all participants live in the north of the country. The results of this study may not be generalizable to the entire Dutch rehabilitation population. As stated above, by the diverse population measured, it was not possible to distinguish severity within diagnoses. As an extension of the current study, future research could focus on specific diagnoses and could more in depth (regarding severity) investigate predictors of HRQoL. Hereby more precise indication values can be formed, which can be useful in setting treatment goals. Additionally prospective research is needed to study the causality of the relationship between movement intensity and HRQoL.

Conclusions

HRQoL in rehabilitation patients was lower compared to that of healthy people. Diagnosis predominantly affects physical functioning, pain, general health and health change. There is a strong relationship between movement intensity and almost all fields of HRQoL. Moreover, in a clinical rehabilitation setting the results of this study can be used as reference values for HRQoL.

Health Related Quality of Life in a Dutch rehabilitation population separated for different subgroups.

PF = physical functioning; SF = social functioning; RP = role limitations–physical; RE = role limitations–emotional; MH = mental health; VT = vitality; BP = bodily pain; GH = general health; HC = health change; y = years; Amp. = amputation; SCI = spinal cord injury; MS = multiple sclerosis; neuro other = other neurological diseases; * clinical relevant difference between groups (difference > 0.5 SD [47]), pooled SDs can be found in Table 2; a Brain injuries from vascular, traumatic or oncological origin and meningitis; b Spina bifida, Parkinson’s Disease and Guillain-Barré Syndrome; c Disabilities such as tumors, fibromyalgia, arthritis, multi trauma, chronic fatigue syndrome and decubitus ulcer. (PDF) Click here for additional data file. (PDF) Click here for additional data file.
  45 in total

1.  Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations.

Authors:  N K Aaronson; M Muller; P D Cohen; M L Essink-Bot; M Fekkes; R Sanderman; M A Sprangers; A te Velde; E Verrips
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

2.  A cross-sectional study of post-amputation pain in upper and lower limb amputees, experience of a tertiary referral amputee clinic.

Authors:  Judith H Davidson; Kok E Khor; Lorraine E Jones
Journal:  Disabil Rehabil       Date:  2010       Impact factor: 3.033

3.  An evaluation of a biopsychosocial framework for health-related quality of life and disability in rheumatoid arthritis.

Authors:  Perry M Nicassio; Morgan A Kay; Mara K Custodio; Michael R Irwin; Richard Olmstead; Michael H Weisman
Journal:  J Psychosom Res       Date:  2011-05-14       Impact factor: 3.006

4.  Correlation between health-related quality of life in veterans with chronic spinal cord injury and their caregiving spouses.

Authors:  Mohammad Hosein Ebrahimzadeh; Farideh Golhasani-Keshtan; Bibi Soheila Shojaee
Journal:  Arch Trauma Res       Date:  2014-11-25

5.  Importance of an individual's evaluation of functional status for health-related quality of life in patients with multiple sclerosis.

Authors:  Miriam Gavelova; Iveta Nagyova; Jaroslav Rosenberger; Martina Krokavcova; Zuzana Gdovinova; Johan W Groothoff; Jitse P van Dijk
Journal:  Disabil Health J       Date:  2015-03-10       Impact factor: 2.554

6.  Use of the SF-36 among persons with spinal cord injury.

Authors:  Martin Forchheimer; Mary McAweeney; Denise G Tate
Journal:  Am J Phys Med Rehabil       Date:  2004-05       Impact factor: 2.159

7.  Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.

Authors:  K Baumstarck; J Pelletier; H Butzkueven; O Fernández; P Flachenecker; E Idiman; S Stecchi; M Boucekine; P Auquier
Journal:  Eur J Neurol       Date:  2013-01-24       Impact factor: 6.089

8.  Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles.

Authors:  A Riazi; J C Hobart; D L Lamping; R Fitzpatrick; J A Freeman; C Jenkinson; V Peto; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

9.  Quality of life of patients with spinal cord injury in Italy: preliminary evaluation.

Authors:  Carla Rognoni; Gabriella Fizzotti; Caterina Pistarini; Silvana Quaglini
Journal:  Stud Health Technol Inform       Date:  2014

10.  Sports participation after rehabilitation: Barriers and facilitators.

Authors:  Eva A Jaarsma; Rienk Dekker; Jan H B Geertzen; Pieter U Dijkstra
Journal:  J Rehabil Med       Date:  2016-01       Impact factor: 2.912

View more
  3 in total

1.  Comparative performance of the EuroQol EQ-5D-5L and the CDC healthy days measures in assessing population health.

Authors:  Maryna Derkach; Fatima Al Sayah; Arto Ohinmaa; Lawrence W Svenson; Jeffrey A Johnson
Journal:  J Patient Rep Outcomes       Date:  2022-06-13

2.  Development of an intervention to stimulate physical activity in hard-to-reach physically disabled people and design of a pilot implementation: an intervention mapping approach.

Authors:  Leonie A Krops; Rienk Dekker; Jan H B Geertzen; Pieter U Dijkstra
Journal:  BMJ Open       Date:  2018-03-16       Impact factor: 2.692

3.  Trajectories of health-related quality of life among people with a physical disability and/or chronic disease during and after rehabilitation: a longitudinal cohort study.

Authors:  B L Seves; F Hoekstra; F J Hettinga; R Dekker; L H V van der Woude; T Hoekstra
Journal:  Qual Life Res       Date:  2020-09-28       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.